Atara Biotherapeutics Announces Presentation of Initial ATA188 Phase 1 Safety Results for Patients with Progressive Multiple Sclerosis at the 5th Congress of the European Academy of Neurology (EAN)

World News: . []

SOUTH SAN FRANCISCO Calif May 15 2019 GLOBE NEWSWIRE -- Atara Biotherapeutics Inc LINK  ATRA a leading off-the-shelf allogeneic T-cell immunotherapy LINK  developing novel treatments for patients with cancer autoimmune and viral d iseases...

More news and information about Atara Biotherapeutics, Inc.

Published By:

Globe Newswire: 13:30 GMT Wednesday 15th May 2019

Published: .

Search for other references to "atara" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us